Biocept (BIOC) Reports Q4 Loss of $0.87/Share

Biocept (NASDAQ: BIOC) reported Q4 EPS of ($0.87), versus ($13.57) reported last year. Revenue for the quarter came in at $76 thousand, versus $19 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy